Trade Mark Journal No.2026/037 11 September 2026

WO0000001934282 (1)

Office of origin: United States of America

Date of International Registration:16 July 2026
Date of designation in the UK: 16 July 2026
Image for mark 1934282 LIDAR QPCR

International priority date claimed: 2 June 2026 (United States of America) (99859698)
Class 1
Chemical and biochemical preparations for scientific or research use, namely, fluorescent oligonucleotide probes, quenched fluorescent oligonucleotide probes, and enzymatic reagents for post-amplification fluorescence detection in nucleic acid assays; reagent kits for nucleic acid analysis comprised primarily of quenched fluorescent oligonucleotide probes, enzymes for dequenching fluorescent probes, buffers, and related biochemical reagents for multiplex target identification following polymerase chain reaction (PCR) amplification, all for laboratory, scientific, or research use.

Medicinal Genomics Corporation

Representative: Austin D. Padgett, Esq. Troutman Pepper Locke LLP, 600 Peachtree Street NE, Suite 3000, Atlanta GA 30308, UNITED STATES OF AMERICA